Osaic Holdings
ABOS icon

Osaic Holdings’s Acumen Pharmaceuticals ABOS Stock Holding History

Osaic Holdings’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.6K Buy
7,350
+1,999
+37% +$4.94K ﹤0.01% 6183
2026
Q1 		$12.6K Sell
5,351
-1,500
-22% -$3.83K ﹤0.01% 6149
2025
Q4 		$14.5K Sell
6,851
-400
-6% -$794 ﹤0.01% 6089
2025
Q3 		$10.4K Hold
7,251
– – ﹤0.01% 6333
2025
Q2 		$8.41K Buy
7,251
+2,251
+45% +$2.42K ﹤0.01% 6260
2025
Q1 		$5.5K Sell
5,000
-10,400
-68% -$14.9K ﹤0.01% 6121
2024
Q4 		$26.5K Buy
15,400
+5,000
+48% +$12K ﹤0.01% 5142
2024
Q3 		$25.8K Hold
10,400
– – ﹤0.01% 5210
2024
Q2 		$25.2K Hold
10,400
– – ﹤0.01% 5176
2024
Q1 		$42.1K Buy
10,400
+10,000
+2,500% +$37.7K ﹤0.01% 4866
2023
Q4 		$1.54K Buy
400
+200
+100% +$594 ﹤0.01% 6627
2023
Q3 		$830 Buy
+200
New +$1.24K ﹤0.01% 6877
2022
Q3 		– Sell
-1
Closed – – 7219
2022
Q2 		$0 Buy
+1
New +$4 ﹤0.01% 7293

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Osaic Holdings's ABOS Position: Q2 2026 in Review

Osaic Holdings increased its Acumen Pharmaceuticals (ABOS) stake by 37% in Q2 2026, buying an estimated $4.94K and bringing the position to 7,350 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6183.

Osaic Holdings first reported a position in ABOS in Q2 2022 and has held it in 13 quarters since. The position peaked at $42.1K in Q1 2024. 96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

  • Osaic Holdings held 7,350 shares of Acumen Pharmaceuticals worth $19.6K as of Q2 2026.
  • Osaic Holdings bought 1,999 Acumen Pharmaceuticals shares in Q2 2026, an estimated $4.94K.
  • Acumen Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6183 holding.
  • Osaic Holdings first reported a position in Acumen Pharmaceuticals in Q2 2022 and has held it in 13 quarters since.
  • Osaic Holdings's Acumen Pharmaceuticals position peaked at $42.1K in Q1 2024.
  • 96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.